NovaBay Pharmaceuticals (NBY)
(Delayed Data from AMEX)
$1.36 USD
-0.17 (-11.11%)
Updated Oct 3, 2025 04:00 PM ET
After-Market: $1.38 +0.02 (1.47%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, NovaBay Pharmaceuticals, Inc. has a market cap of $9.19M, which represents its share price of $1.53 multiplied by its outstanding shares number of 6.01M. As a small-cap company, NBY's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
NBY 1.36 -0.17(-11.11%)
Will NBY be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for NBY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NBY
Brookdale Senior Living (BKD) Reports Q1 Loss, Lags Revenue Estimates
NovaBay Pharmaceuticals (NBY) Upgraded to Buy: Here's Why
NBY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Verve Therapeutics (VERV) Reports Q3 Loss, Tops Revenue Estimates
Other News for NBY
NBY forms 20 Day Moving Average Resistance on October 3
NovaBay (NBY) Files for $200 Million Mixed Securities Shelf
NBY Crossed Above 20 Day Moving Average on October 2
NovaBay files $200M mixed securities shelf
NovaBay files $200M mixed securities shelf